FDs vs Small Savings Schemes: Which One Offers Better Returns in 2025?

If you’re a conservative investor, chances are you’ve considered Fixed Deposits (FDs) for their safety and assured returns. However, government-backed small savings schemes, like those from the post office, often offer better interest rates, especially for long-term investments. Let’s take a closer look at how these two options compare in terms of returns and tax benefits.

What Returns Do Bank FDs Offer?

Most leading banks currently offer interest rates between 6.6% and 7.1% per year on 1-year FDs. These rates have slightly decreased after the repo rate cut on April 9.

Also Read, Old vs New Tax Regime: Which One Should You Choose Before Filing Your ITR?

One-year FD interest rates:

  • SBI: 6.7%

  • HDFC Bank: 6.6%

  • ICICI Bank: 6.7%

  • Kotak Mahindra Bank: 7.1%

Keep in mind that interest rates may vary depending on tenure and market conditions.

How Much Do Small Savings Schemes Offer?

Post office schemes usually offer higher interest rates, especially for longer tenures. Here’s what different schemes offer currently:

Instrument Interest Rate (p.a.)
Kisan Vikas Patra 7.5%
National Savings Time Deposit (1 yr) 6.9%
National Savings Time Deposit (5 yr) 7.5%
National Savings Certificate (NSC) 7.7%
Public Provident Fund (PPF) 7.1%
Sukanya Samriddhi Account 8.2%
Senior Citizen Savings Scheme 8.2%
National Savings Recurring Deposit 6.7%

Clearly, some small savings schemes provide significantly better returns than regular bank FDs, especially for senior citizens and long-term savers.

What About Tax Benefits?

Fixed Deposits:

  • Interest is taxable and added to your total income.

  • No special tax benefits under the new tax regime.

  • Only 5-year tax-saving FDs qualify for deduction under Section 80C (old regime only).

Small Savings Schemes:

  • Many schemes like PPF, Sukanya Samriddhi, and Senior Citizen Schemes offer Section 80C benefits (under old regime).

  • Interest from PPF is tax-free.

  • Under the new tax regime, 80C benefits do not apply, but interest remains more tax-friendly than FDs.

Which One Should You Choose?

  • If safety and short-term liquidity are your priorities, bank FDs may work better.

  • If you’re planning for long-term goals (like retirement or your child’s education), small savings schemes offer higher returns and better tax advantages.

  • Senior citizens can benefit more from schemes tailored for them, like the Senior Citizen Savings Scheme.

Final Thought

Both FDs and small savings schemes are reliable and safe investment options. Your choice should depend on your financial goals, time horizon, and whether you’re under the old or new tax regime. A mix of both can also help you balance returns and flexibility.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.     

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.    

Old vs New Tax Regime: Which One Should You Choose Before Filing Your ITR?

As the financial year has ended, it’s time to prepare to file your income tax return (ITR) before the deadline of July 31, 2025. One of the key decisions you’ll need to make is whether to go with the old tax regime or the new tax regime. Here’s a simple guide to help you understand the differences and choose the one that works best for you.

Difference in Tax Slabs (FY 2024-25)

New Tax Regime

  • No tax on income up to ₹7 lakh (after rebate under Section 87A)

  • Slab-wise tax rates:

    • Up to ₹3 lakh – Nil

    • ₹3 lakh to ₹7 lakh – 5%

    • ₹7 lakh to ₹10 lakh – 10%

    • ₹10 lakh to ₹12 lakh – 15%

    • ₹12 lakh to ₹15 lakh – 20%

    • Above ₹15 lakh – 30%

Old Tax Regime

  • Up to ₹2.5 lakh – Nil

  • ₹2.5 lakh to ₹5 lakh – 5%

  • ₹5 lakh to ₹10 lakh – 20%

  • ₹10 lakh to ₹50 lakh – 30%

What About Standard Deduction?

  • Old Regime: Standard deduction is ₹50,000

  • New Regime (FY 2024–25): Now increased to ₹75,000

Know More ITR Filing for AY 2025-26: When Will Income Tax Return Filing Begin? Here’s What Taxpayers Need to Know. 

Deductions: What You Can and Can’t Claim

Old Regime:
 Allows deductions under many sections like:

  • Section 80C (Investments like PPF, ELSS)

  • Section 80D (Health insurance)

  • Section 80G (Donations)

  • Section 80DD (Disability support)

New Regime:
 Most of these deductions are not allowed. However, you can still claim:

  • 80CCD(2): Employer contribution to NPS

  • 80CCH: Contribution to Agniveer Corpus Fund

  • 80JJAA: Deduction for new employees (for businesses)

Do You Have to Choose the New Regime?

  • The new tax regime is the default option.

  • If you want to stay with the old regime, you must opt for it specifically while filing your ITR.

Which Tax Regime Should You Pick?

  • It depends on your income and how much you invest in tax-saving options.

  • If you don’t claim many deductions, the new regime might save you more tax.

  • If you invest a lot in 80C, pay insurance premiums, or donate, the old regime may offer better tax benefits.

Choosing the right regime can help you reduce your tax liability smartly. Always plan based on your income, lifestyle, and financial goals.

Conclusion

Deciding between the old and new tax regimes doesn’t have to be confusing. Review your income, savings, and eligible deductions before choosing. If in doubt, use an income tax calculator or consult a tax expert. Making the right choice now can lead to significant savings later.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.     

Investments in the securities market are subject to market risks, read all the related documents carefully before investing. 

RBI’s Rate Cuts in 2025: What It Means for FD Investors and How to Plan Ahead

The Reserve Bank of India (RBI), in its April 2025 policy meeting, reduced the repo rate by 25 basis points (bps), bringing it down to 6.00%. This marks the second rate cut of the year, totalling 50 bps so far in 2025. The RBI has also changed its policy stance from ‘neutral’ to ‘accommodative’, signalling that more rate cuts could come if inflation remains under control.

Let’s understand what this means for bank depositors and how you can plan your finances better.

Why Did RBI Cut Rates?

The RBI decided to lower interest rates due to global uncertainties, especially after new tariff announcements by the U.S. government under Trump 2.0. These policies have created economic pressure around the world. As a result, stock markets have become volatile, and investors are looking for safer options. Gold prices are rising due to this uncertainty.

Inflation in India, especially food inflation, has been falling. This gives the RBI more room to cut rates to support economic growth without worrying too much about rising prices.

Read More Stock Markets (NSE, BSE) and Bank Holiday on April 18 for Good Friday. 

What Happens to Bank FDs Now?

As RBI cuts rates, banks usually reduce FD interest rates in response. Some banks have already lowered their FD rates even before the April policy announcement. Going forward, more banks are likely to recalibrate and cut FD rates to avoid mismatches in how much they pay vs. how much they earn.

So, if you’re planning to invest in a fixed deposit, now may be a good time to lock in at current rates before they drop further.

Who Will Be Most Affected?

People who prefer low-risk investments like bank FDs—especially senior citizens and retirees—may see a drop in their returns. Since they often rely on FDs for steady income, falling interest rates can make it harder for them to manage monthly expenses.

Why FDs Still Make Sense

Even with falling rates, FDs offer stability, especially when markets are volatile. Equity markets may rebound occasionally, but the global situation remains unpredictable.

FDs also provide capital safety, as deposits up to ₹5 lakh per depositor per bank are insured by DICGC. To maximise this protection, you can spread your deposits across different banks or accounts.

Use the FD Laddering Strategy

To make the most of your FD investments, consider using the laddering strategy:

  • Invest in FDs with different maturity periods (e.g. 6 months, 1 year, 2 years). 
  • When one FD matures, you can use the money or reinvest it based on interest rates at that time. 
  • This gives you regular access to funds without breaking long-term FDs early. 

Final Thoughts: Why Asset Allocation Matters in 2025

This year shows us why diversifying your investments is so important. FDs can be a key part of your portfolio—not just for conservative investors, but even for those willing to take risks.

FDs ensure that:

  • You have liquidity to manage short-term or emergency needs. 
  • You avoid withdrawing from long-term investments during a crisis. 
  • Your short-term goals stay on track without market exposure. 

Lastly, a smart approach to saving and investing, based on your needs and financial goals—will always lead you toward long-term financial success.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.     

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.  

WTO Cuts Global Trade Forecast: India Faces Export Challenges Amid Rising Tariffs

India’s exports could come under pressure next year as the World Trade Organisation (WTO) has sharply lowered its global trade forecast for 2025. The WTO now expects world merchandise trade volume to shrink by 0.2% in 2025, a big drop from its earlier projection of 2.7% growth. This revision comes after factoring in the U.S.’s decision to impose a 10% baseline tariff on imports.

India’s Trade Performance in 2024

In 2024, India’s merchandise exports grew by 2.6%, while imports increased by 6.6%. But the global trade environment may turn more challenging due to rising tariff barriers and policy uncertainty.

Read More How Much Does an Audi Cost After Union Budget 2025 Reduced Customs Duty on Imported Cars?

Trump-Era Tariffs Could Return

The WTO warned that if the U.S. reintroduces country-specific reciprocal tariffs, especially under Donald Trump’s administration, it could lead to a 1.5% drop in global trade in 2025. The report added that rising uncertainty around trade policies is also making global trade conditions more volatile.

Regional Impact of Trade Policy Changes

The effects of these tariff changes are not the same across regions. According to the updated forecast:

  • North America is expected to reduce global trade growth by 1.7 percentage points, pushing overall trade into negative territory.

  • Asia and Europe will still add to trade growth, but their contributions will be smaller.

  • Asia’s share in global trade growth could be cut in half to just 0.6 percentage points.

  • Other regions like Africa, West Asia, and Latin America will contribute positively but to a lesser extent than before.

US-China Trade Disruption to Redirect Exports

The WTO also noted that the U.S.-China trade conflict will likely divert trade routes. As the U.S. reduces imports from China—particularly in textiles, apparel, and electrical goods—other countries may find new opportunities to fill that gap. This could benefit some least-developed countries by allowing them to boost their exports to the U.S.

Services Trade Also to Suffer

While services like travel and logistics are not directly affected by tariffs, they still feel the impact. A slowdown in goods trade reduces demand for related services. The WTO now expects global services trade to grow by only 4% in 2025 and 4.1% in 2026—down from earlier forecasts of 5.1% and 4.8%.

Slower Global GDP Growth Expected

The global economy is also likely to be affected. The WTO projects global GDP to grow by 2.2% in 2025—down 0.6 percentage points from the no-tariff-change scenario. The biggest impact will be felt in:

  • North America: −1.6 points

  • Asia: −0.4 points

  • South and Central America: −0.2 points

If trade policy uncertainty spreads, global GDP growth could fall by as much as 1.3 percentage points.

India’s Position in Global Trade Slips

India slipped slightly in global trade rankings in 2024:

  • It moved down to 14th among top merchandise exporters (excluding intra-EU trade), though its global share stayed at 2.2%.

  • It dropped to 7th among top merchandise importers, with its share holding at 3.4%.

  • In services, India ranked 6th in both exports and imports of commercial services (excluding intra-EU trade). However, its share of service exports fell from 5.4% to 5.3%, and for imports from 4.2% to 4.1%.

Conclusion

The WTO’s revised outlook signals turbulent times ahead for global trade, especially for emerging economies like India. While India saw modest export growth in 2024, rising protectionism, US-China trade tensions, and policy unpredictability could limit its trade momentum. India may need to diversify export markets, tap into emerging opportunities, and strengthen its domestic economy to cushion the impact of a potential global trade slowdown.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.    

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.   

Zynext Ventures, a Subsidiary of Zydus Lifescience, Invests in Feldan to Advance Cell-Based Drug Delivery

On April 16, 2025, Zynext Ventures USA LLC—the venture capital arm of Zydus Lifesciences—announced its investment in Feldan Therapeutics, a Canadian clinical-stage pharmaceutical company. Feldan focuses on developing new treatments using its special technology that helps deliver medicines directly inside cells.

Innovative Technology to Target Skin and Lung Diseases

Feldan has created a unique “Shuttle peptide” technology. This allows therapeutic molecules to enter cells more effectively and reach their targets. The company’s lead drug, FLD-103, is designed to treat basal cell carcinoma (BCC), a common skin cancer. It’s injected directly into the tumour, where the Shuttle system helps deliver a Hedgehog pathway inhibitor inside cancer cells. The goal is to offer a safer, non-surgical treatment option that improves patients’ quality of life.

Feldan is also working on a lung disease program. It uses the same technology to deliver treatments to hard-to-reach lung cells, helping address the rising need for better respiratory therapies.

Read More Hospital Stocks Like Narayana, HCG, Yatharth Share Price Surge as Demand Rises for Advanced Healthcare. 

Zydus Leaders Support the Vision

Dr. Sharvil Patel, Managing Director of Zydus Lifesciences, said that the company is committed to advancing innovative treatments that address major gaps in healthcare. He added that the investment will support Feldan in developing safer, targeted therapies for skin and lung conditions.

Jay Kothari, Director at Zynext Ventures, highlighted that Feldan’s platform aligns with Zynext’s mission to invest in breakthrough innovations that can change the future of medicine.

About Zydus Lifesciences

Zydus Lifesciences is a global pharmaceutical company that works to help people live healthier lives. With a team of 27,000 employees—including 1,400 scientists—the company develops and markets a wide range of treatments, including vaccines, biologics, and biosimilars. Zydus is known for launching several first-of-their-kind products in the past decade.

On April 16, 2025, Zydus Lifesciences share price opened at ₹883.15, reached a high of ₹887.25, and touched a low of ₹813.00 during the trading session.

Conclusion

This partnership marks a strategic step toward revolutionising drug delivery by combining Zynext’s vision for innovation with Feldan’s cutting-edge platform. Together, they aim to bring safer, more targeted treatments to patients suffering from skin and lung diseases, improving healthcare outcomes globally.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.    

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.   

Wipro Q4 2025 Net Profit Rises 6.4%; Profit Surges 18.9%

Wipro Limited has announced its financial performance for the fourth quarter and the full financial year ending March 31, 2025. The company posted a 6.4% growth in net profit for Q4 and an impressive 18.9% increase for FY25. Operating margins also expanded, reaching 17.5% in Q4—up 1.1% compared to the same quarter last year. For the full year, margins stood at 17.1%, reflecting a 0.9% year-on-year growth.

Financial Highlights for Q4 FY25

In the March quarter, Wipro reported gross revenue of ₹225.0 billion ($2.63 billion), showing a 0.8% increase from the previous quarter and a 1.3% rise from the same period last year. However, revenue from the IT services segment declined 1.2% quarter-on-quarter and 2.3% year-on-year to $2.60 billion. 

Net income stood at ₹35.7 billion ($417.8 million), reflecting a sequential growth of 6.4% and a 25.9% increase compared to Q4 FY24. Earnings per share rose to ₹3.4 ($0.04), up 6.2% QoQ and 25.8% YoY. Total bookings were strong at $3.96 billion, with large deal bookings reaching $1.76 billion, marking a 48.5% year-on-year growth. Operating cash flow was ₹37.5 billion ($438.5 million), representing 104.4% of net income for the quarter. Voluntary attrition came down to 15.0% on a trailing 12-month basis.

Read More Hospital Stocks Like Narayana, HCG, Yatharth Share Price Surge as Demand Rises for Advanced Healthcare. 

Financial Highlights for FY25

For the full year, gross revenue was ₹890.9 billion ($10.4 billion), slightly down by 0.7% compared to FY24. IT services revenue came in at $10.51 billion, a decline of 2.7% year-on-year. On the positive side, large deal bookings rose 17.5% to $5.4 billion, though total bookings dropped 3.8% to $14.3 billion. 

Net income for the year stood at ₹131.4 billion ($1.54 billion), up 18.9% year-on-year, and earnings per share increased to ₹12.6 ($0.15), a 20.3% YoY growth. Operating cash flow for the year was robust at ₹169.4 billion ($1.98 billion), amounting to 128.2% of net income.

Guidance for Q1 FY26:
 Wipro expects revenue from its IT Services business to range between $2.51 billion and $2.56 billion in the quarter ending June 30, 2025. This guidance indicates a possible decline of 1.5% to 3.5% in constant currency terms. The forecast is based on assumed exchange rates, including USD/INR at 86.60.

Srini Pallia, Wipro’s CEO and Managing Director, highlighted that the company ended FY25 on a high note with two mega deal wins, stronger large deal bookings, and growth in top client accounts. He emphasised improved client satisfaction and Wipro’s ongoing investments in talent and AI-led consulting capabilities. 

Aparna Iyer, CFO, added that operating margins expanded 110 basis points YoY in Q4 and 90 basis points over the full year. She also pointed out that the company generated strong cash flows, which stood at nearly $2 billion for the year, equivalent to 128.2% of net income.

About Wipro

Wipro Ltd is a global leader in technology services and consulting, known for building innovative digital solutions for complex business challenges. With a workforce of over 230,000 people across 65 countries, Wipro helps clients achieve their transformation goals while fostering sustainability and growth in a rapidly evolving world.

On April 16, Wipro share price opened at ₹244.00, touched a high of ₹248.45, and dropped to a low of ₹241.20 before closing at ₹247.60, up 1.48% for the day.

Conclusion

Wipro’s FY25 performance reflects its strategic focus on high-value deals, operational efficiency, and client satisfaction. Despite a cautious Q1 FY26 outlook, the company remains committed to long-term growth through investments in AI, talent, and innovation. Investors and stakeholders will be keenly watching how these efforts translate into results in the coming quarters.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.    

   

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.   

Top Gainers and Losers on April 16, 2025: Sensex Ends Higher for 3rd Day; IndusInd Bank, Axis Bank Shine

Indian stock markets extended their rally for the third consecutive session on Wednesday, driven by strong buying in financials—especially private banks—and select oil & gas stocks. 

The BSE Sensex opened with a 262-point gain at 76,996 but briefly turned negative, dipping to 76,544 following weak global sentiment amid escalating US-China trade tensions. The drop came after U.S. President Donald Trump threatened tariffs as high as 245% on Chinese imports in response to China’s retaliatory measures. 

Despite early losses, the Sensex recovered sharply, touching an intraday high of 77,110—marking a swing of 556 points from the day’s low. It eventually closed 309 points higher at 77,044, registering a 0.4% gain. The index has now advanced 3,197 points over the past three trading days. 

Meanwhile, the NSE Nifty 50 slipped to a low of 23,273 but rebounded to a peak of 23,452 before ending the day at 23,433—up 104.60 points or 0.45%. The Nifty has surged by 1,038 points during the recent three-day rally. 

Here are the top gainers and losers of the day:  

Top Gainers of the Day 

Symbol  Open  High  Low  LTP  %chng 
INDUSINDBK  747  794.4  733  785.5  6.74 
AXISBANK  1,122.70  1,163.50  1,112.60  1,161.00  4.33 
ONGC  232.69  242  231.72  240.84  3.5 
TRENT  4,922.00  5,049.50  4,852.00  5,042.00  3.38 
ADANIPORTS  1,210.00  1,235.50  1,201.60  1,235.50  2.04 
  • IndusInd Bank surged 6.74% to ₹785.50, after opening at ₹747 and hitting a high of ₹794.40. 
  • Axis Bank gained 4.33%, closing at ₹1,161 after touching an intraday high of ₹1,163.50. 
  • ONGC rose 3.5% to ₹240.84, with a day’s low of ₹231.72. 
  • Trent advanced 3.38% to ₹5,042 after hitting a high of ₹5,049.50. 
  • Adani Ports added 2.04%, ending the session at ₹1,235.50. 

Top Losers of the Day 

Symbol  Open  High  Low  LTP  %chng 
MARUTI  11,768.00  11,768.00  11,615.00  11,665.00  -1.6 
HINDALCO  618.15  619.35  602  609.65  -1.29 
TATAMOTORS  625  625  613.6  616.1  -0.98 
INFY  1,425.00  1,427.50  1,396.80  1,412.20  -0.97 
NTPC  362.5  363  357.9  359.35  -0.87 
  • Maruti Suzuki declined 1.6% to ₹11,665, slipping from a high of ₹11,768. 
  • Hindalco fell 1.29% to ₹609.65, after touching a low of ₹602. 
  • Tata Motors ended 0.98% lower at ₹616.10. 
  • Infosys dipped 0.97%, closing at ₹1,412.20. 
  • NTPC eased 0.87%, settling at ₹359.35. 

Conclusion 

Despite global headwinds from escalating US-China trade tensions, Indian equity markets remained resilient, buoyed by strong buying in banking and energy stocks. The sustained rally over the past 3 sessions reflects investor confidence in domestic fundamentals, especially in the financial sector. However, volatility driven by global developments may continue to influence short-term market sentiment. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.    

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.   

Hospital Stocks Like Narayana, HCG, Yatharth Share Price Surge as Demand Rises for Advanced Healthcare

Shares of major hospital chains like Narayana Hrudayalaya, HealthCare Global Enterprises (HCG), and Yatharth Hospitals gained strongly on Wednesday, driven by a positive outlook for the healthcare sector. These stocks have risen between 7% and 16% in the last 3 days, showing strong investor interest.

Stocks Hit New Highs as Market Sees Strong Momentum

Narayana Hrudayalaya rose by 4% to ₹1,807.40, and HCG climbed 2% to ₹586.35—both touching their highest levels ever. Yatharth Hospitals jumped 6% to ₹512.85 during the day. Meanwhile, the BSE Sensex was down 0.10% at 76,655 around 11:10 am, showing that hospital stocks outperformed the broader market.

Read More Why Gold Prices Touched a New Record High in International Market?

Growing Demand for Specialised Treatment is Driving Growth

The demand for specialised care like cancer treatment and complex surgeries is increasing. This is leading to higher earnings for hospitals, as seen through rising Average Revenue per Occupied Bed (ARPOB) and better occupancy levels. With more elective surgeries being carried out and hospital capacities expanding, revenue is expected to grow further. Medical tourism is also playing a bigger role, contributing about 5–7% of total income and growing faster than the rest of the sector.

HCG to See Big Changes with KKR Gaining Control

HCG, a leader in cancer care for the past 30 years, is seeing major investment activity. Global investment firm KKR will acquire up to 77% stake in the company, including public share purchases. 

Narayana Hrudayalaya Expands with a Focus on International Markets

Narayana Hrudayalaya operates 19 hospitals, 2 heart centres in India, and a Cayman Islands hospital. With over 5,900 operational beds and a capacity of 6,300, the company has reported a 42% surge in stock price so far in 2025, thanks to strong earnings. Management believes the Cayman facility will be a key growth driver in the future.

Yatharth Hospitals Recovers Sharply from Lows

Yatharth Hospitals, which operates 5 super-speciality hospitals across Delhi NCR and Madhya Pradesh, has seen a 49% rise from its 52-week low of ₹345.35 (hit in March 2025). The stock had previously touched ₹692.85 in November 2024, showing strong investor interest in its recovery and growth.

Conclusion

The strong performance of Narayana Hrudayalaya, HCG, and Yatharth Hospitals reflects the growing demand for specialised healthcare services, including cancer treatment and advanced surgeries. With an expanding market for medical tourism, increasing hospital occupancy, and solid expansion plans, these companies are well-positioned for continued growth. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.       

      

Investments in the securities market are subject to market risks. Read all the related documents carefully before investing.     

Schaeffler India Declares ₹28 Final Dividend, a 1400% Payout for FY24

Schaeffler India has surprised its shareholders with a huge final dividend announcement. The auto components giant is offering a ₹28 dividend per share, which is 1400% of the face value of ₹2. Here’s what investors need to know about this big payout:

₹28 Dividend Per Share for FY24

Schaeffler India has proposed a final dividend of ₹28 per share for the financial year ending December 2024. With a face value of ₹2, this translates to a massive 1400% dividend—a clear reflection of the company’s rewarding approach to its investors.

Read More India’s Diamond, Gold and Silver Jewellery Exports Decline in FY25.  

Record Date: April 23, 2025

To receive the dividend, investors must hold shares of Schaeffler India on or before April 23, 2025. This is the record date which determines who qualifies for the payout.

Dividend Payment Timeline

Once approved at the company’s Annual General Meeting (AGM) on April 23, 2025, the dividend will be credited to shareholders within 30 days—by May 23, 2025.

Consistent Dividend Growth

Schaeffler India has a strong history of rewarding shareholders. In recent years, it paid out:

  • ₹24 per share in 2023

  • ₹26 per share in 2024

  • And now ₹28 in 2025

This consistent increase shows the company’s healthy financial performance and shareholder focus.

Recent Stock Performance

As of April 16, 2025, at 10:09 AM IST, Schaeffler India share price is trading at ₹3,186.20, up ₹48.60 or 1.55% for the day. The stock opened at ₹3,148.40 and has touched a high of ₹3,202.00 and a low of ₹3,132.80 so far. The company’s market capitalisation stands at ₹49,830 crore, with a price-to-earnings (P/E) ratio of 53.04 and a dividend yield of 0.88%. Over the past 52 weeks, the stock has reached a high of ₹4,951.00 and a low of ₹2,823.00.

Final Thoughts

This hefty dividend currently makes Schaeffler India one of the most attractive dividend-paying stocks. Long-term investors might see this as a positive signal, while new investors should consider the ex-date and market trends before jumping in.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.     

    

Investments in the securities market are subject to market risks. Read all the related documents carefully before investing.     

Key Corporate Actions: Sanofi, Akme Fintrade, Garment Mantra and Others in Focus Ahead of Ex-Date

Several stocks will be in the spotlight as they trade ex-date on Thursday, April 17, 2025, due to recent corporate announcements. These include Sanofi Consumer Healthcare India, Akme Fintrade (India), Garment Mantra Lifestyle, Sylph Technologies, and Tirupati Tyres. Here’s what investors need to know:

Sanofi Consumer Healthcare India – Dividend

Sanofi Consumer has announced an interim dividend of ₹55 per share. The stock will trade ex-dividend on April 17, 2025, and shareholders on record by this date will be eligible for the dividend payout.

Read More India’s Diamond, Gold and Silver Jewellery Exports Decline in FY25. 

Akme Fintrade (India) – Stock Split

Akme Fintrade is set to undergo a stock split, where each fully paid share of ₹10 will be split into 10 shares of ₹1 each. The record date is April 18, 2025. This move is intended to make shares more affordable for retail investors.

Garment Mantra Lifestyle – Rights Issue

Garment Mantra has announced a rights issue worth up to ₹50 crore.

  • Issue price: ₹1.20 per share (includes ₹0.20 premium).

  • Initial payment: ₹0.30 per share (₹0.25 face value + ₹0.05 premium).

  • Remaining: To be paid in future calls.

  • Ratio: 39 new shares for every 20 held.

  • Record date: April 17, 2025.

Sylph Technologies – Rights Issue

Sylph Technologies is offering a rights issue of 48.9 crore shares:

  • Price: ₹1 per share.

  • Ratio: 15 shares for every 11 held.

  • Record date: April 18, 2025.

  • Shareholders can renounce their rights.

  • Note: The company is under ASM LT Stage 1 on BSE.

Tirupati Tyres – Rights Issue

Tirupati Tyres has announced a rights issue of 4.89 crore shares:

  • Price: ₹10 per share.

  • Ratio: 2 shares for every 1 held.

  • Record date: April 17, 2025.

  • Renunciation rights apply.

  • The stock is currently under ESM Stage 2 on BSE.

Understanding the Ex-Date

The ex-date is the date when a stock starts trading without the benefit of a dividend, rights issue, or stock split. To be eligible for these corporate actions, you must own the shares before the ex-date. The company finalises eligible shareholders on the record date.

Conclusion

Investors should track these key corporate actions to make informed decisions ahead of the ex-date. Holding shares before this date ensures eligibility for the respective benefits, including dividends, bonus rights, or split shares.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.     

    

Investments in the securities market are subject to market risks. Read all the related documents carefully before investing.